Literature DB >> 3899904

Endocrine changes associated with the human aging process: III. Effect of age on the number of calcitonin immunoreactive cells in the thyroid gland.

K O'Toole, C Fenoglio-Preiser, N Pushparaj.   

Abstract

The thyroid glands obtained at autopsy from 60 patients ranging in age from 16 to 89 years were immunostained for calcitonin (CT) by the peroxidase-antiperoxidase procedure. The numbers of CT immunoreactive cells identified were 0.99 +/- 1.07/mm2 in the young patients (16 to 39 years of age), 0.99 +/- 1.46/mm2 in the middle-aged (40 to 59 years of age), and 2.97 +/- 3.69/mm2 in the elderly (60 years of age and older). The results were not statistically significant because of the large standard deviation. The CT immunoreactive cells tended to aggregate in clusters in a pattern similar to that seen in C-cell nodules in older persons.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3899904     DOI： 10.1016/s0046-8177(85)80276-8

Source DB:  PubMed          Journal:  Hum Pathol        ISSN： 0046-8177            Impact factor:   3.466


  10 in total

1.  C cells evolve at the same rhythm as follicular cells when thyroidal status changes in rats.

Authors:  Inés Martín-Lacave; María J Borrero; José C Utrilla; José M Fernández-Santos; Manuel de Miguel; Jesús Morillo; Juan M Guerrero; Rocío García-Marín; Esperanza Conde
Journal:  J Anat       Date:  2009-03       Impact factor: 2.610

Review 2.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

Review 3.  C-cell hyperplasia and medullary thyroid microcarcinoma.

Authors:  J A Albores-Saavedra; J E Krueger
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

Review 4.  [Thyroid C cells and their pathology: Part 1: normal C cells, - C cell hyperplasia, - precursor of familial medullary thyroid carcinoma].

Authors:  S Ting; S Synoracki; K W Schmid
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

5.  Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndrome.

Authors:  Zoran Erlic; Michael M Hoffmann; Maren Sullivan; Gerlind Franke; Mariola Peczkowska; Igor Harsch; Matthias Schott; Helmut E Gabbert; Matti Valimäki; Simon F Preuss; Kornelia Hasse-Lazar; Dariusz Waligorski; Mercedes Robledo; Andrzej Januszewicz; Charis Eng; Hartmut P H Neumann
Journal:  J Clin Endocrinol Metab       Date:  2009-11-11       Impact factor: 5.958

Review 6.  Thyroid C-Cell Biology and Oncogenic Transformation.

Authors:  Gilbert J Cote; Elizabeth G Grubbs; Marie-Claude Hofmann
Journal:  Recent Results Cancer Res       Date:  2015

Review 7.  Thyroid safety in patients treated with liraglutide.

Authors:  M Gallo
Journal:  J Endocrinol Invest       Date:  2013-02       Impact factor: 4.256

8.  The clinical implications of a positive calcitonin test for C-cell hyperplasia in genetically unaffected members of an MEN2A kindred.

Authors:  R M Landsvater; A G Rombouts; G J te Meerman; J M Schillhorn-van Veen; M J Berends; R A Geerdink; A Struyvenberg; C H Buys; C J Lips
Journal:  Am J Hum Genet       Date:  1993-02       Impact factor: 11.025

9.  Abnormal distribution and hyperplasia of thyroid C-cells in PTEN-associated tumor syndromes.

Authors:  Eduardo Zambrano; Ingrid Holm; Jonathan Glickman; Stephen Huang; Antonio Perez-Atayde; Harry P W Kozakewich; Robert C Shamberger; Vânia Nosé
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

10.  Association of RET codon 691 polymorphism in radiation-induced human thyroid tumours with C-cell hyperplasia in peritumoural tissue.

Authors:  A Bounacer; J A Du Villard; R Wicker; B Caillou; M Schlumberger; A Sarasin; H G Suárez
Journal:  Br J Cancer       Date:  2002-06-17       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.